Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-17T17:17:32.404Z Has data issue: false hasContentIssue false

Hepatitis B Vaccination Coverage and Documented Seroprotection among Matriculating Healthcare Students at an Academic Institution in the United States

Published online by Cambridge University Press:  02 January 2015

Rania A. Tohme*
Affiliation:
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
Bruce Ribner
Affiliation:
Emory University, Atlanta, Georgia
Michael J. Huey
Affiliation:
Emory University, Atlanta, Georgia
Philip R. Spradling
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Centers for Disease Control and Prevention, 1600 Clifton Road, N.E., Mailstop G37, Atlanta, GA 30333 (rtohme@cdc.gov)

Extract

We evaluated hepatitis B vaccination coverage and documentation of antibody to hepatitis B surface antigen (anti-HBs) concentration among a cohort of healthcare students. Of 4,075 students, 59.8% had documentation of vaccination and 83.8% had anti-HBs concentration greater than or equal to 10 mIU/mL. Documenting hepatitis B vaccination and anti-HBs concentration among healthcare students is needed to prevent transmission in healthcare settings.

Type
Concise Communication
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR-18):142.Google Scholar
2.US Department of Health and Human Services. Healthy People 2010: With Understanding and Improving Health and Objective for Improving Health. 2 vols. 2nd ed. Washington, DC: US Government Printing Office, 2002.Google Scholar
3.Centers for Disease Control and Prevention. Achievements in public health: hepatitis B vaccination—United States, 1982–2002. MMWR Morb Mortal Wkly Rep 2002;51:549552.Google Scholar
4.Nichol, KL, Olson, R. Medical students' exposure and immunity to vaccine-preventable diseases. Arch Int Med 1993;153:19131916.Google Scholar
5.Pavlopoulou, ID, Daikos, GL, Tzivaras, A, et al.Medical and nursing students with suboptimal protective immunity against vaccine-preventable diseases. Infect Control Hosp Epidemiol 2009;30:10061011.Google Scholar
6.Trevisan, A, Bruno, A, Mongillo, M, et al.Prevalence of markers for hepatitis B virus and vaccination compliance among medical school students in Italy. Infect Control Hosp Epidemiol 2008;29:11891191.Google Scholar
7.Baer, G, Bonhoeffer, J, Schaad, UB, Heininger, U. Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine 2005;23:20162020.Google Scholar
8.Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:10181023.Google Scholar
9.McMahon, BJ, Dentinger, CM, Bruden, D, et al.Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009;200:13901396.CrossRefGoogle ScholarPubMed
10.Averhoff, F, Mahoney, F, Coleman, P, Schatz, G, Hurwitz, E, Margolis, H. Immunogenicity of hepatitis B vaccines: implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998;15:18.Google Scholar